483
Mission Pharmacal CompanyFDA 483 - Mission Pharmacal Company - February 07, 2014
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Mission Pharmacal Co, a drug manufacturer, identified a repeat observation concerning the lack of written procedures for in-process controls and testing. The firm failed to conduct in-process blend sample testing for prenatal products, exemplified by CitraNatal Assure tablets. This indicates a significant and recurring issue with quality control processes.
Open in Dashboard
ID · 4a5b0198-5b64-4f4b-8326-3e1ac06b0f95